<DOC>
	<DOCNO>NCT00964535</DOCNO>
	<brief_summary>The purpose study compare test product Budesonide/formoterol Easyhaler market product Symbicort Turbohaler term drug absorb bloodstream .</brief_summary>
	<brief_title>Bioequivalence Study Budesonide/Formoterol Easyhaler Symbicort Turbohaler Asthmatics</brief_title>
	<detailed_description />
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<mesh_term>Charcoal</mesh_term>
	<criteria>Males female age 1860 year document diagnosis asthma Prebronchodilator force expiratory volume one second ( FEV1 ) least 80 % predict value The asthma stable regular treatment least 4 week screen . Use oral , parenteral rectal corticosteroid within 4 week precede screen Respiratory infection within 4 week precede screen Any condition require regular concomitant treatment likely need concomitant treatment study medicinal product pharmacokinetic interaction budesonide Any disorder clinically significant abnormal laboratory value physical finding may interfere interpretation test result cause health risk subject he/she participates study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2010</verification_date>
</DOC>